Forward-looking statement

Elbit Systems Awarded a $200 Million Contract to Supply Helicopter Self-Protection Suits to a Country in Asia-Pacific

Retrieved on: 
Thursday, November 17, 2022
Securities Act of 1933, Intellectual property, Environment, Forward-looking statement, Annual report, Company, Patent, Securities Exchange Act of 1934, Program, U.S. Securities and Exchange Commission, Private Securities Litigation Reform Act, Form 20-F, Elbit Systems, Global health, Risk management, Thermoplastic

Forward-looking statements are based on management's current expectations, estimates, projections and assumptions about future events.

Key Points: 
  • Forward-looking statements are based on management's current expectations, estimates, projections and assumptions about future events.
  • Forwardlooking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended.
  • Elbit Systems Ltd., its logo, brand, product, service and process names appearing in this Press Release are the trademarks or service marks of Elbit Systems Ltd. or its affiliated companies.
  • Reference to or use of a product, service or process other than those of Elbit Systems Ltd. does not imply recommendation, approval, affiliation or sponsorship of that product, service or process by Elbit Systems Ltd.

HANZA AB (publ) successfully completes a directed new share issue of 3,500,000 shares and raises proceeds of approximately SEK 147 million

Retrieved on: 
Thursday, November 17, 2022
Disclosure, Financial services, II, Crime, US, Nasdaq Stockholm, Investment, Pareto, Person, Communication, Securities Act of 1933, Board of directors, Board, Forward-looking statement, Prejudice, CEO, Breast self-examination, Director, EEA, Finance, Intention, United Kingdom, Financial Services and Markets Act 2000, Growth, Calendar, Alpha, Company, Prospectus, Review, SEK, Directive 2014/65/EU, Security (finance), Renewable energy, Medical device, Bank, Cryptocurrency, Property management, Public relations, Regulation, EU, Central Europe

Through the Directed New Share Issue, HANZA will receive proceeds amounting to approximately SEK 147 million before transaction related costs (of which SEK 10.5 million will be paid later and is conditioned by an approval from an extraordinary general meeting).

Key Points: 
  • Through the Directed New Share Issue, HANZA will receive proceeds amounting to approximately SEK 147 million before transaction related costs (of which SEK 10.5 million will be paid later and is conditioned by an approval from an extraordinary general meeting).
  • Through the Directed New Share Issue, HANZA will receive proceeds amounting to approximately SEK 147 million, before transaction related costs (of which SEK 10.5 million will be paid later and is conditioned by an approval from an extraordinary general meeting).
  • The Directed New Share Issue, less the allocation to Frna Invest AB, comprises 3,250,000 new shares at a subscription price of SEK 42.00 per share and the Company will hereby receive approximately SEK 136.5 million before transaction related costs.
  • The Directed New Share Issue entails a dilution of approximately 8.9 percent based on the total number of shares in HANZA after the Directed New Share Issue.

Sailfish Reports Q3 2022 Results

Retrieved on: 
Wednesday, November 16, 2022
TSX, NSR, News, SEDAR, Legislation, Forward-looking statement, TSX Venture Exchange, Gold, Analysis, View, Company, Multimedia, OTCQX, Bank, Online shopping, Basilica of San Albino, Sailfish

Subsequent to Q3 2022 Activity:

Key Points: 
  • Subsequent to Q3 2022 Activity:
    On October 14, 2022, the Company paid a dividend of $0.0125 per common share.
  • Subsequent to September 30, 2022, Sailfish purchased 299,000 common shares on-market which have not been cancelled.
  • In addition to the above, the Company cancelled 448,600 common shares subsequent to September 30, 2022.
  • On November 11, 2022, Barnwell Investments LLC notified the Company that they will be no longer participating in the Proposed Transaction.

NIKOLA ADDS INDUSTRY VETERAN TO LEAD TRUCK SALES AND SERVICE

Retrieved on: 
Wednesday, November 16, 2022
SEC, Growth, Commerce, U.S. Securities and Exchange Commission, Security (finance), Nikola Corporation, FCEV, Forward-looking statement, Leadership, University, Senior, Industry, Sale, International, Multimedia, Failure, CEO, Navistar International, International Design Excellence Awards, BEV, Commercial Operating System (COS), Volvo, OEM, Transport, Kenworth, Solution, Renewable energy, Electric power industry, COVID-19

PHOENIX, Nov. 16, 2022 /PRNewswire/ -- Nikola Corporation (Nasdaq: NKLA), a global leader in zero-emissions transportation and energy supply and infrastructure solutions, today announced that Bruce Kurtt has joined its executive team as Senior Vice President of Sales and Commercial Operations.

Key Points: 
  • Reporting to Nikola President and CEO, Michael Lohscheller, Kurtt will lead all commercial activities for Nikola, including oversight for its sales, sales operations, dealer support and relationships, charging solutions, and service and warranty teams.He succeeds Pablo Koziner, who has elected to leave the company in December.
  • For over 30 years, Kurtt has held executive leadership roles in the heavy and medium duty commercial vehicle industry.
  • Kurtt has owned and operated truck dealerships, frequently earning International's Circle of Excellence Award.
  • These forward-looking statements speak only as of the date hereof and Nikola specifically disclaims any obligation to update these forward-looking statements.

TUT Fitness Group Launches TUT Infinite 8™

Retrieved on: 
Wednesday, November 16, 2022
Technology, Goal, Environment, Intention, TUT, News, SEDAR, Forward-looking statement, Consultant, IP, Company, Program, Failure, COVID-19, Virus, Overalls, Comment, Risk management, Security (finance)

Certain statements in this release are forward-looking statements or information, which include the preferred affiliate sales program, TUT Fitness Group licensing its technology, expectations, and outcomes from the TUT Fitness Group's patented technology, the expected outcomes and benefits of the TUT Infinite 8 program and the expected outcomes of working with Luiz Balcers and Blake Holman, development of technologies, the Company's mission and goals, the benefits and expectations from the patents and overall IP portfolio, customer demand for TUT Fitness Group's products, increase in distribution and sales, global expansion, the updates to TUT products, future plans, regulatory approvals and other matters.

Key Points: 
  • Certain statements in this release are forward-looking statements or information, which include the preferred affiliate sales program, TUT Fitness Group licensing its technology, expectations, and outcomes from the TUT Fitness Group's patented technology, the expected outcomes and benefits of the TUT Infinite 8 program and the expected outcomes of working with Luiz Balcers and Blake Holman, development of technologies, the Company's mission and goals, the benefits and expectations from the patents and overall IP portfolio, customer demand for TUT Fitness Group's products, increase in distribution and sales, global expansion, the updates to TUT products, future plans, regulatory approvals and other matters.
  • Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future.
  • The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect.
  • The forward-looking statements contained in this news release are made as of the date of this news release.

NeuroSense Receives Regulatory Approval to Commence Patient Enrollment in Italy for its Phase 2b Trial in ALS

Retrieved on: 
Wednesday, November 16, 2022
Quality of life, Celecoxib, RNA, ALS, EMA, European Medicines Agency, Massachusetts General Hospital, Forward-looking statement, Ciprofloxacin, Safety, Neurodegeneration, FDA, Paralysis, Hope, Company, Italian Medicines Agency, Therapy, Patent, Death, Patient, Parkinson's disease, NASDAQ, Amyotrophic lateral sclerosis, Inflammation, Nature, SOC, Alzheimer's disease, Diagnosis, NDE, Food, Biomarker, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Pharmaceutical industry, EU

The Phase 2b ( NCT05357950 ) double-blind, placebo-controlled, multinational clinical trial aims to assess PrimeC's efficacy, as well as safety and tolerability, in people living with ALS.

Key Points: 
  • The Phase 2b ( NCT05357950 ) double-blind, placebo-controlled, multinational clinical trial aims to assess PrimeC's efficacy, as well as safety and tolerability, in people living with ALS.
  • The study is enrolling and randomizing 69 people living with ALS in a 2:1 ratio to receive PrimeC or placebo, respectively.
  • Primary endpoints of the study include assessment of ALS-biomarkers, evaluation of clinical efficacy, and improvement in quality of life.
  • Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate.

Lightspeed named one of Canada's Enterprise Fast 15 winners in Deloitte's Technology Fast 50(TM) program

Retrieved on: 
Wednesday, November 16, 2022
Commerce, TSX, Toronto Stock Exchange, Telecommunication, TMX, New, Technology, Central American Technological University, City, Consumer, CBRE, News, SEDAR, Forward-looking statement, Risk, Result, Deloitte, Analysis, Company, Deloitte Technology Fast 500, CCI, NYSE, Vector Institute, Multimedia, EDC, Program, Enterprise, U.S. Securities and Exchange Commission, CEO, Love, Conversation, Nature, Entrepreneurship, Council, Financial condition report, Clean technology, EDGAR, Management, Online shopping, Speed of light

"This year's Enterprise Fast 15 winners represent a high level of excellence and success as members of Canada's elite in the technology sector," stated Anders McKenzie, partner and national leader for the Technology Fast 50TM program at Deloitte Canada.

Key Points: 
  • "This year's Enterprise Fast 15 winners represent a high level of excellence and success as members of Canada's elite in the technology sector," stated Anders McKenzie, partner and national leader for the Technology Fast 50TM program at Deloitte Canada.
  • The Deloitte Technology Fast 50 program is Canada's pre-eminent technology awards program.
  • Celebrating its 25th anniversary, the program recognizes business growth, innovation, and entrepreneurship in four distinct categories: Technology Fast 50 ranking, Enterprise Fast 15, Clean Technology, and Companies-to-Watch.
  • The program also recognizes companies within the North American Technology Fast 500 ranking identifying thriving technology companies in the United States and Canada.

NextNav Announces Sale of Common Shares

Retrieved on: 
Wednesday, November 16, 2022
PNT, Ecosystem, SEC, Growth, 3D, U.S. Securities and Exchange Commission, Security (finance), Acquisition, Engineering, Forward-looking statement, Industry, Sale, GPS, Company, Nasdaq, Navigation, Time, NextNav, Private Securities Litigation Reform Act, NASDAQ, Pinnacle, Traction, Form 4, NN, Management, Risk management

MCLEAN, Va., Nov. 16, 2022 /PRNewswire/ -- NextNav Inc. (NASDAQ: NN) ("NextNav" or the "Company"), a leader in next generation GPS and 3D geolocation, today announced that certain members of NextNav's executive leadership team sold approximately 796 thousand shares of NextNav's common stock on November 15, 2022, as reported with the SEC on Form 4.

Key Points: 
  • MCLEAN, Va., Nov. 16, 2022 /PRNewswire/ -- NextNav Inc. (NASDAQ: NN) ("NextNav" or the "Company"), a leader in next generation GPS and 3D geolocation, today announced that certain members of NextNav's executive leadership team sold approximately 796 thousand shares of NextNav's common stock on November 15, 2022, as reported with the SEC on Form 4.
  • The sale of common shares was primarily done to cover tax obligations associated with the vesting of certain restricted stock units and awards.
  • Simultaneously, entities controlled by NextNav Director, Neil Subin, purchased approximately 280 thousand shares, also reported on Form 4.
  • NextNav executives selling shares include, Chairman Gary Parsons, CEO Ganesh Pattabiraman, CFO Chris Gates, SVP Systems Engineering Arun Raghupathy and SVP Network Operations David Knutson.

Concord Medical Announces the Successful Holding of the Second Annual Academic Meeting with the world well-known MD Anderson

Retrieved on: 
Wednesday, November 16, 2022
Monroe Dunaway Anderson, Anderson, Fudan University, Forward-looking statement, Meeting, University, Company, Nursing management, Education, NYSE, CCM, Research, Phrase, The Meeting, Patient, Radiation, Renji Hospital, Hospital, Shanghai Cancer Center, Oncology, MD Anderson Cancer Center, Method, Ruijin Hospital, Cancer, Pharmaceutical industry, Medical device, Medical imaging, Immunotherapy, Bedside

12 experts from MD Anderson participated in the Meeting, including nine of which as guest speakers and three as moderators and opening speakers.

Key Points: 
  • 12 experts from MD Anderson participated in the Meeting, including nine of which as guest speakers and three as moderators and opening speakers.
  • Dr. Jianyu Yang, Chairman and Chief Executive Officer of Concord Medical, commented, "I would like to express my heartfelt thanks to the experts who spoke on and participated in the Meeting.
  • MD Anderson is one of the best-known cancer treatment centers globally and the largest cancer center in the United States.
  • Leveraging years of strategic cooperation, MD Anderson and Shanghai Concord Cancer Center successfully cohosted the First Annual Academic Meeting in November 2021.

BorgWarner to Invest $500 Million in Wolfspeed, Securing up to $650 Million in Annual Capacity for Silicon Carbide Devices

Retrieved on: 
Wednesday, November 16, 2022
Information, Perception, Growth, Technology, U.S. Securities and Exchange Commission, Goal, Tax, Security (finance), Acquisition, Forward-looking statement, Silicon, Risk, Forecasting, Motor vehicle, Failure, COVID-19, BorgWarner, Private Securities Litigation Reform Act, OEM, Risk management, Wolfspeed

Wolfspeedis a registered trademark of Wolfspeed, Inc.

Key Points: 
  • Wolfspeedis a registered trademark of Wolfspeed, Inc.
    For more than 130 years, BorgWarner has been a transformative global product leader bringing successful mobility innovation to market.
  • Today, we're accelerating the world's transition to eMobility to help build a cleaner, healthier, safer future for all.
  • This press release contains forward-looking statements by Wolfspeed involving risks and uncertainties, both known and unknown, that may cause Wolfspeed's actual results to differ materially from those indicated.
  • Forward-looking statements are not guarantees of performance, and BorgWarner's actual results may differ materially from those expressed, projected or implied in or by such forward-looking statements.